GlassScriptPhysician profile
Aria Jamshidi
NPI 1447781950
$11,461.26
in general payments reported to CMS, 2019-2025
18 companies · $5,463 in 2025
The $5,463 reported for 2025 was more than what 81% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $39.57 · 2021: $850 · 2022: $1,880 · 2023: $2,502 · 2024: $726 · 2025: $5,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,608 · Food and Beverage: $3,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,607.87 |
| Food and Beverage | $3,083.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,504.58 | 2025 | Velys |
| Stryker Corporation | $1,902.88 | 2022-2023 | Serrato, Hydroset, Adherus Autospray Dural Sealant |
| Nuvasive, INC. | $1,677.24 | 2023 | Xlif, Pcm, Reline |
| Globus Medical, INC. | $1,313.17 | 2023-2025 | Xlif, Excelsius Gps, Reline |
| Alphatec Spine, INC | $942.13 | 2025 | Other - Miscellaneous |
| Amplify Surgical, INC. | $724.12 | 2025 | |
| Depuy Synthes Sales INC. | $520.62 | 2024-2025 | Trialtis, Teligen, Symphony |
| Medtronic, INC. | $484.12 | 2021-2023 | Stealthstation S8 Platform |
| Penumbra, INC. | $458.62 | 2021 | |
| Carlsmed, INC. | $252.08 | 2022 | |
| Kuros Biosciences USA, INC | $228.58 | 2025 | Magnetos |
| Si-Bone, INC. | $166.68 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $121.90 | 2022 | |
| Celgene Corporation | $52.37 | 2025 | Zeposia |
| Osteomed LLC | $39.57 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $35.12 | 2025 | |
| Lemaitre Vascular, INC. | $20.29 | 2025 | Xenosure Biologic Patch |
| Integra Lifesciences Corporation | $17.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aria Jamshidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.